X
skip to main content
Logo
media conference

Press Releases

  • September 07, 2016

    Triple-negative breast cancer (TNBC) persists as a deadly form of breast cancer today that lacks effective therapies. Now, a newly formed and funded Terry Fox Research Institute team hopes to employ a four-pronged approach to change the odds for TNBC patients.

  • September 06, 2016

    In order for cancer to grow inside our bodies, it must overcome a series of control mechanisms that are important for tissue growth. One mechanism which is responsible for body organ size is aptly called the “Hippo” pathway.

  • September 06, 2016

    TFRI’s Vancouver-based prostate cancer progression team is primed and ready to continue its world-class research on advanced, drug-resistant tumours after receiving a five-year renewal of Terry Fox funding.

  • September 06, 2016

    TFRI’s prolific lymphoid cancer team began their research with a simple question: “Why do two-thirds of lymphoma patients recover, while the remainder does not?” A decade later their work is being renewed as they continue their mission to find solutions to this problem so all patients diagnosed with lymphoid cancer have better outcomes.

  • September 02, 2016

    Both around the world and in Canada, teams of researchers are working hard to harness the power of a patient’s own immune system to eradicate cancer through immunotherapy. Hailed now as the fourth arm of treatment, a newly funded TFRI pan-Canadian research team hopes this promising approach will give new hope and options to patients who need it the most.

  • September 02, 2016

    A newly funded TFRI “dream team” plans to tackle the most lethal and aggressive brain tumour that occurs in adults by focusing not on the original tumour, but on the relapsed cancer.

  • July 14, 2016

    Dr. Gang Zheng and a team of biomedical researchers have discovered a "smart," organic, biodegradable nanoparticle that uses heat and light in a controlled manner to potentially target and ablate tumours with greater precision.

  • July 14, 2016

    International stem cell scientists, co-led in Canada by Terry Fox-funded scientist Dr. John Dick and in the Netherlands by Dr. Gerald de Haan, have discovered the switch to harness the power of cord blood and potentially increase the supply of stem cells for cancer patients needing transplantation therapy to fight their disease.

  • June 14, 2016

    Terry Fox-funded cancer researchers in BC led an international study to develop a new method to improve diagnosis of a rare sub-type of ovarian cancer that has been notoriously difficult to accurately identify. The team has created an algorithm to diagnose and predict the clinical course of granulosa cell cancers of the ovary.

  • June 03, 2016

    Terry Fox-funded researcher Dr. David Malkin, The Hospital for Sick Kids, Toronto, Ontario, was in Columbus, Ohio this week to co-lead the 2016 International Li-Fraumeni Syndrome (LFS) Conference. TFRI funds two projects led by Dr. Malkin, including one focusing solely on LFS.

  • April 22, 2016

    Congratulations to Dr. Victor Ling, TFRI's President and Scientific Director, who has been honoured with the LifeSciences BC Dr. Don Rix Award for Lifetime Achievement. The award celebrates his many contributions to cancer research over his career.

  • April 21, 2016

    A report by Statistics Canada suggests that women have significantly better survival outcomes than men for a majority of cancers in Canada. While the reasons are not yet understood, hormonal influences are thought to be an important factor. The full report, "Differences in cancer survival in Canada by sex" can be read on the Statistics Canada website.

  • April 21, 2016

    TFRI is now accepting submissions from researchers and research teams for our 2017 funding cycle. For more information see the competition pages for Terry Fox New Frontiers Program Project Grants, TFRI Translational Programs and Terry Fox New Investigator Awards.

  • March 15, 2016

    Rolly Fox-smallRolland (Rolly) Murray Fox was born March 22, 1935 in Winnipeg, Manitoba. Rolly was the third of nine children born to Rodney Fox and Bertha (Shale) Fox...

  • February 10, 2016

    Dr. Ralph DaCosta will use a $450,000 New Investigator award from TFRI to try to find new and innovative ways to study the complex tumor microenvironment to develop new treatment strategies for pancreatic cancer and prevent deadly tumour recurrences.

Back to Top